Mr. Staggs elevated from "interim" to
"permanent" CEO as SWK advances multiple initiatives in
2023
Ms. Dotter joined SWK's Board of Directors in
February 2022
DALLAS, Jan. 3, 2023
/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or
the "Company"), a life science focused specialty finance company
catering to small- and mid-sized commercial-stage companies, today
announced that Jody Staggs has been
named the company's Chief Executive Officer. In September 2022, Mr. Staggs was promoted to the
position of President and interim Chief Executive Officer.
Effective January 1, 2023, Mr. Staggs
holds the titles of President and Chief Executive Officer of SWK
Holdings.
Additionally, SWK has appointed Laurie
Dotter as Chair of the Board of Directors. Ms. Dotter joined
the Board as an independent director in February 2022 and serves on the compensation,
audit, and governance committees.
"Officially elevating Jody to Chief Executive Officer of SWK is
a reflection of his strong leadership following his promotion to
president and interim CEO in September
2022," said Ms. Dotter. "Under Jody's direction, SWK has
progressed several important initiatives, including closing
multiple financings, improving the company's credit facility, and
further strengthening and developing SWK's team. We are
excited by SWK's prospects and look forward to working with Jody
and the management team to continue growing SWK's platform with a
focus on generating strong shareholder returns."
Mr. Staggs commented: "I want to thank the Board for entrusting
me to lead SWK and supporting our mission to be the leader in
custom financings for small and mid-sized commercial-stage life
science companies. We are well positioned for what is expected to
be an active 2023 based on heightened interest in our non-dilutive
financial offerings. As president and CEO, I look forward to
working with Laurie and our team to optimize our capital structure
and continue deploying capital in opportunities where we believe
strong risk-adjusted returns are likeliest."
Ms. Dotter has served in executive leadership roles in several
investment companies that delivered attractive investment returns
on commercial real estate operating companies, development and
management companies, and portfolios requiring repositioning to
enhance value. In addition to her tenure as a director at SWK, Ms.
Dotter serves in advisory or board roles at the Employee Retirement
System of Texas, Texas Treasury
Safekeeping Trust Company, and Stratus Properties Inc. Some of her
prior roles include President of Transwestern Investment Group;
founding partner of Corporate Properties Trust I, II and III;
executive investment officer at Hunt Oil Co.'s real estate
investment arm; director of Real Estate Investments at the
Teacher Retirement System of Texas; and as a Director of Financial
Consulting Services at PricewaterhouseCoopers.
About SWK Holdings Corporation
SWK Holdings Corporation is a life science-focused specialty
finance company partnering with small- and mid-sized
commercial-stage healthcare companies. SWK provides non-dilutive
financing to fuel the development and commercialization of
lifesaving and life-enhancing medical technologies and products.
SWK's unique financing structures provide flexible financing
solutions at an attractive cost of capital to create long-term
value for all SWK stakeholders. SWK's solutions include structured
debt, traditional royalty monetization, synthetic royalty
transactions, and asset purchases typically ranging in size from
$5.0 million to $25.0 million. SWK also owns Enteris BioPharma,
whose Peptelligence® and ProPerma® drug
delivery technologies create oral formulations of peptide-based and
BCS class II, III, and IV small molecules. Additional information
on the life science finance market is available on the Company's
website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Statements including words such as "believes," "expects,"
"anticipates," "intends," "estimates," "plan," "will," "may," "look
forward," "intend," "guidance," "future" or similar expressions are
forward-looking statements. Because these statements reflect SWK's
current views, expectations and beliefs concerning future events,
these forward-looking statements involve risks and uncertainties.
Investors should note that many factors, as more fully described
under the caption "Risk Factors" and elsewhere in SWK's Form 10-K,
Form 10-Q and Form 8-K filings with the Securities and Exchange
Commission and as otherwise enumerated herein, could affect the
Company's future financial results and could cause actual results
to differ materially from those expressed in such forward-looking
statements. The forward-looking statements in this press release
are qualified by these risk factors. These are factors which,
individually or in the aggregate, could cause the Company's actual
results to differ materially from expected and historical results.
You should not place undue reliance on any forward-looking
statements, which speak only as of the date they are made. We
assume no obligation to publicly update any forward-looking
statements, whether as a result of new information, future
developments or otherwise.
View original
content:https://www.prnewswire.com/news-releases/swk-holdings-names-jody-staggs-chief-executive-officer-and-appoints-laurie-dotter-as-chair-of-the-board-301712335.html
SOURCE SWK Holdings Corporation
